Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
155 hedge funds and large institutions have $201M invested in Immunogen Inc in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 57 reducing their positions, and 23 closing their positions.
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
2% less funds holding
Funds holding: 158 → 155 (-3)
21% less capital invested
Capital invested by funds: $254M → $201M (-$52.8M)
44% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 57
51% less call options, than puts
Call options by funds: $542K | Put options by funds: $1.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.75M |
| 2 |
Renaissance Technologies
New York
|
+$1.56M |
| 3 |
KBC Group
Brussels,
Belgium
|
+$635K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$579K |
| 5 |
Millennium Management
New York
|
+$552K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$4.54M |
| 2 |
Morgan Stanley
New York
|
-$3.94M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.26M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.99M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$2.7M |
IMGN Hedge Fund Activity: Q3 2016 in Review
155 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2016, worth a combined $201M — down 21% from $254M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of IMGN and 22 opened new positions — a net loss of 1 holder — while 57 trimmed existing stakes and 32 added.
The largest buyer was Panagora Asset Management, adding an estimated $1.75M. The largest seller was State Street, cutting an estimated $4.54M.
- 155 institutional investors held Immunogen Inc (IMGN) as of Q3 2016, down from 158 in Q2 2016.
- Funds reported $201M of Immunogen Inc stock for Q3 2016, down 21% quarter-over-quarter.
- 22 funds opened new Immunogen Inc positions in Q3 2016 and 23 closed out, a net change of -1 holder.
- The largest Immunogen Inc buyer in Q3 2016 was Panagora Asset Management, an estimated $1.75M added.
- The largest Immunogen Inc seller in Q3 2016 was State Street, an estimated $4.54M sold.
Based on aggregated 13F filings for Q3 2016.